Lowering cholesterol, 1988. Rationale, mechanisms, and means.
Open Access
- 1 June 1988
- journal article
- review article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 81 (6), 1653-1660
- https://doi.org/10.1172/jci113501
Abstract
No abstract availableThis publication has 53 references indexed in Scilit:
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Role of apolipoprotein E in lipoprotein metabolismAmerican Heart Journal, 1987
- Functional Activities of Hepatic Lipoprotein ReceptorsAnnual Review of Physiology, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Regulation of Hepatic Lipoprotein Receptors in the Dog. RAPID REGULATION OF APOLIPOPROTEIN B,E RECEPTORS, BUT NOT OF APOLIPOPROTEIN E RECEPTORS, BY INTESTINAL LIPOPROTEINS AND BILE ACIDSJournal of Clinical Investigation, 1983
- Reduction of Serum Cholesterol in Heterozygous Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1983
- Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug RegimenNew England Journal of Medicine, 1981
- Increased coronary mortality in relatives of hypercholesterolemic school children: the Muscatine study.Circulation, 1979